167 related articles for article (PubMed ID: 37036052)
21. Orexin B inhibits proliferation and stimulates specialized function of cultured rat calvarial osteoblast-like cells.
Ziolkowska A; Rucinski M; Tyczewska M; Malendowicz LK
Int J Mol Med; 2008 Dec; 22(6):749-55. PubMed ID: 19020772
[TBL] [Abstract][Full Text] [Related]
22. The physiology and pharmacology of the orexins.
Smart D; Jerman J
Pharmacol Ther; 2002; 94(1-2):51-61. PubMed ID: 12191593
[TBL] [Abstract][Full Text] [Related]
23. Human pheochromocytomas express orexin receptor type 2 gene and display an in vitro secretory response to orexins A and B.
Mazzocchi G; Malendowicz LK; Aragona F; Rebuffat P; Gottardo L; Nussdorfer GG
J Clin Endocrinol Metab; 2001 Oct; 86(10):4818-21. PubMed ID: 11600547
[TBL] [Abstract][Full Text] [Related]
24. The SK-N-MC cell line expresses an orexin binding site different from recombinant orexin 1-type receptor.
Wieland HA; Söll RM; Doods HN; Stenkamp D; Hurnaus R; Lämmle B; Beck-Sickinger AG
Eur J Biochem; 2002 Feb; 269(4):1128-35. PubMed ID: 11856342
[TBL] [Abstract][Full Text] [Related]
25. Orexin research: patent news from 2016.
Boss C; Roch C
Expert Opin Ther Pat; 2017 Oct; 27(10):1123-1133. PubMed ID: 28631980
[TBL] [Abstract][Full Text] [Related]
26. Orexins in the regulation of the hypothalamic-pituitary-adrenal axis.
Spinazzi R; Andreis PG; Rossi GP; Nussdorfer GG
Pharmacol Rev; 2006 Mar; 58(1):46-57. PubMed ID: 16507882
[TBL] [Abstract][Full Text] [Related]
27. Orexins and their receptors: structural aspects and role in peripheral tissues.
Voisin T; Rouet-Benzineb P; Reuter N; Laburthe M
Cell Mol Life Sci; 2003 Jan; 60(1):72-87. PubMed ID: 12613659
[TBL] [Abstract][Full Text] [Related]
28. Discovery of Nivasorexant (ACT-539313): The First Selective Orexin-1 Receptor Antagonist (SO1RA) Investigated in Clinical Trials.
Williams JT; Bolli MH; Brotschi C; Sifferlen T; Steiner MA; Treiber A; Gatfield J; Boss C
J Med Chem; 2024 Feb; 67(4):2337-2348. PubMed ID: 38331429
[TBL] [Abstract][Full Text] [Related]
29. Orexins/hypocretins acting at Gi protein-coupled OX 2 receptors inhibit cyclic AMP synthesis in the primary neuronal cultures.
Urbańska A; Sokołowska P; Woldan-Tambor A; Biegańska K; Brix B; Jöhren O; Namiecińska M; Zawilska JB
J Mol Neurosci; 2012 Jan; 46(1):10-7. PubMed ID: 21547533
[TBL] [Abstract][Full Text] [Related]
30. Activation of orexin/hypocretin type 1 receptors stimulates cAMP synthesis in primary cultures of rat astrocytes.
Woldan-Tambor A; Biegańska K; Wiktorowska-Owczarek A; Zawilska JB
Pharmacol Rep; 2011; 63(3):717-23. PubMed ID: 21857082
[TBL] [Abstract][Full Text] [Related]
31. Involvement of orexin-A in the regulation of neuronal activity and emotional behaviors in central amygdala in rats.
Pan YP; Liu C; Liu MF; Wang Y; Bian K; Xue Y; Chen L
Neuropeptides; 2020 Apr; 80():102019. PubMed ID: 31980205
[TBL] [Abstract][Full Text] [Related]
32. Orexin B/hypocretin 2 increases glutamatergic transmission to ventral tegmental area neurons.
Borgland SL; Storm E; Bonci A
Eur J Neurosci; 2008 Oct; 28(8):1545-56. PubMed ID: 18793323
[TBL] [Abstract][Full Text] [Related]
33. Functions of the orexinergic/hypocretinergic system.
Kukkonen JP; Holmqvist T; Ammoun S; Akerman KE
Am J Physiol Cell Physiol; 2002 Dec; 283(6):C1567-91. PubMed ID: 12419707
[TBL] [Abstract][Full Text] [Related]
34. Comparison of Orexin 1 and Orexin 2 Ligand Binding Modes Using X-ray Crystallography and Computational Analysis.
Rappas M; Ali AAE; Bennett KA; Brown JD; Bucknell SJ; Congreve M; Cooke RM; Cseke G; de Graaf C; Doré AS; Errey JC; Jazayeri A; Marshall FH; Mason JS; Mould R; Patel JC; Tehan BG; Weir M; Christopher JA
J Med Chem; 2020 Feb; 63(4):1528-1543. PubMed ID: 31860301
[TBL] [Abstract][Full Text] [Related]
35. Activation of orexin 1 receptors in the periaqueductal gray of male rats leads to antinociception via retrograde endocannabinoid (2-arachidonoylglycerol)-induced disinhibition.
Ho YC; Lee HJ; Tung LW; Liao YY; Fu SY; Teng SF; Liao HT; Mackie K; Chiou LC
J Neurosci; 2011 Oct; 31(41):14600-10. PubMed ID: 21994376
[TBL] [Abstract][Full Text] [Related]
36. Orexins/hypocretins modulate the activity of NPY-positive and -negative neurons in the rat intergeniculate leaflet via OX1 and OX2 receptors.
Palus K; Chrobok L; Lewandowski MH
Neuroscience; 2015 Aug; 300():370-80. PubMed ID: 26022361
[TBL] [Abstract][Full Text] [Related]
37. Biochemical and electrophysiological characterization of almorexant, a dual orexin 1 receptor (OX1)/orexin 2 receptor (OX2) antagonist: comparison with selective OX1 and OX2 antagonists.
Malherbe P; Borroni E; Pinard E; Wettstein JG; Knoflach F
Mol Pharmacol; 2009 Sep; 76(3):618-31. PubMed ID: 19542319
[TBL] [Abstract][Full Text] [Related]
38. Nicotine up-regulates expression of orexin and its receptors in rat brain.
Kane JK; Parker SL; Matta SG; Fu Y; Sharp BM; Li MD
Endocrinology; 2000 Oct; 141(10):3623-9. PubMed ID: 11014216
[TBL] [Abstract][Full Text] [Related]
39. Cultured rat calvarial osteoblast-like cells are provided with orexin type 1 receptors.
Ziolkowska A; Rucinski M; Tortorella C; Tyczewska M; Nussdorfer GG; Malendowicz LK
Int J Mol Med; 2007 Dec; 20(6):779-82. PubMed ID: 17982683
[TBL] [Abstract][Full Text] [Related]
40. The hypocretins are weak agonists at recombinant human orexin-1 and orexin-2 receptors.
Smart D; Jerman JC; Brough SJ; Neville WA; Jewitt F; Porter RA
Br J Pharmacol; 2000 Apr; 129(7):1289-91. PubMed ID: 10742282
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
